Autoimmune polyendocrine syndrome type 3
Autoimmune thyroiditis with one other non-Addison autoimmune disease.
Autoimmune polyendocrine syndrome type 3 (APS-3) is a condition characterized by the coexistence of autoimmune thyroiditis and at least one other autoimmune disease, excluding Addison's disease. It is classified into subtypes based on the associated autoimmune condition: type 3a with type 1 diabetes, type 3b with pernicious anemia, and type 3c with alopecia, vitiligo, or other organ-specific autoimmune disease. The syndrome is part of a broader group of autoimmune polyglandular syndromes (APS), which involve autoimmune reactions against multiple endocrine and non-endocrine organs.
Quick Facts
- Field
- Endocrinology, Rheumatology
- Symptoms
- Any symptoms associated with its constituent diseases
- Complications
- Autoimmune thyroiditis (Always), Celiac Disease, Type I Diabetes, Autoimmune hypophysitis, Systemic Lupus Erythematosus, Sjögren's Syndrome, Vitiligo (May or May not be Present)
- Onset
- Any Age
- Duration
- Lifelong
- Causes
- Combination of Genetic and Environmental Factors
- Risks
- Family History of APS III or other Autoimmune Diseases
- Diagnosis
- Serum antibody assays; Autoimmune Thyroiditis Required for Diagnosis
- Differential
- Autoimmune Polyendocrine Syndrome Type II, APECED, IPEX
- Treatment
- Depends on Constituent Diseases
- Prognosis
- Normal Lifespan
- Frequency
- ~ 2-3% of population
Facts from the source article.
Lore & Background
Autoimmune polyendocrine syndrome type 3 is defined by the presence of autoimmune thyroid disease alongside at least one other autoimmune disorder, excluding Addison's disease. Subtypes are classified based on the specific additional condition: type 3a involves type 1 diabetes, type 3b involves pernicious anemia, and type 3c involves alopecia, vitiligo, or other organ-specific autoimmune diseases. The syndrome is one of four primary types of autoimmune polyglandular syndromes, with APS-1, APS-2, and APS-4 covering other combinations.
Reader's Guide
Autoimmune polyendocrine syndrome type 3 represents a significant category within autoimmune polyglandular syndromes, highlighting the frequent co-occurrence of autoimmune thyroid disease with other organ-specific autoimmune conditions. Its classification into subtypes aids in clinical recognition and management, particularly given the high prevalence of associated disorders like type 1 diabetes and chronic atrophic gastritis. The syndrome's frequency of 1.4 to 2 per 100,000 people, with no ethnic preference, underscores its relevance across populations. Understanding APS-3 helps clinicians anticipate and monitor for additional autoimmune diseases in patients with autoimmune thyroiditis, improving patient outcomes through early detection and coordinated care.
Did You Know?
- Autoimmune polyendocrine syndrome type 3 excludes Addison's disease and hypoparathyroidism.
- Type 3b involves autoimmune thyroid disease with pernicious anemia.
- Chronic atrophic gastritis occurs in 39% of cases of APS-3.
Frequently Asked Questions
Who is Autoimmune polyendocrine syndrome type 3?
APS-3 is a rare autoimmune condition in which chronic thyroid inflammation coexists with at least one additional autoimmune disorder, as long as Addison's disease is not among them. It belongs to the broader family of autoimmune polyglandular syndromes that target multiple endocrine and non-endocrine organs.
What are Autoimmune polyendocrine syndrome type 3's subtypes?
The syndrome splits into three recognized branches: 3a pairs thyroiditis with type 1 diabetes, 3b pairs it with pernicious anemia, and 3c links it to alopecia, vitiligo, or another organ-specific autoimmune condition. Type 1 diabetes shows up in roughly 20–30% of cases, while chronic atrophic gastritis accounts for about 39%.
How does Autoimmune polyendocrine syndrome type 3's story progress?
There is no single 'ending'; instead, the condition is managed long-term by treating each autoimmune component as it manifests. Because new autoimmune diseases can emerge over time, ongoing monitoring of both endocrine and non-endocrine organs is the standard approach.
Why is Autoimmune polyendocrine syndrome type 3 important in the APS lineup?
It affects approximately 1.4 to 2 people per 100,000 and shows no discernible ethnic-group preference, making it a globally relevant diagnosis. Its importance lies in distinguishing thyroid-plus-one-autoimmune-disease clusters from the more well-known APS-1, which involves Addison's disease and hypoparathyroidism.
What conditions are explicitly excluded from Autoimmune polyendocrine syndrome type 3?
Addison's disease and hypoparathyroidism are the two conditions that, if present alongside autoimmune thyroiditis, would shift the diagnosis into a different APS category. This exclusion is precisely what separates APS-3 from its sibling syndromes in the broader polyglandular family.
More in Syndromes 1-24
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced